Beyond Strategic Advancement: Empowering the Future of Diagnostics
We believe technology matters only when it transforms lives. From the very beginning, our mission has been clear: to make
Strategic Technology Transfer
A long-term production and technology transfer agreement with Brazil was signed, reinforcing CHIL’s commitment to sustainable global manufacturing partnerships.
Innovation and Intellectual Property
CHIL initiated patent applications and product development efforts focused on the detection of breast cancer and breast anomalies, signaling a…
CHIL & Italian Partner Showcase Synergy in Diagnostics
From November 13 to 16, 2023, CHIL participated in MEDICA Messe Düsseldorf in a joint presence with its Italian partner.…
CHIL COVID-19 Antigen Test Ranks Among Top Performers in Germany
Based on end-user experiences in Germany, CHIL’s COVID-19 Antigen Test was ranked among the top four companies in terms of…
CHIL COVID-19 Rapid Antigen Test Demonstrates High Accuracy in U.S. Clinical Study
On 15 June 2022, an observational and prospective clinical performance study of the CHIL™ COVID-19 Rapid Antigen Test received approval…
CHIL Founder Discusses Post-Pandemic Insights in CORONOMICS Interview
In April 2023, as part of a European Union research initiative, a European academic conducted an in-depth interview with CHIL…
CHIL Engages with the Middle East Diagnostics Community
From February 6 to 9, 2023, CHIL participated in Medlab Middle East in Dubai, continuing its long-standing engagement in the…
CHIL Makes First Appearance in Veterinary Sector at 18th AGROEXPO
From 1–5 February 2023, CHIL participated for the first time in the veterinary segment at the 18th International Agriculture and…
CHIL Founder Highlights Local Diagnostic Manufacturing on Pakistani Television
Hilda Cil, Founder of CHIL, appeared on Pakistani national television with her experienced team to provide guidance and support for…